Cyamemazine
NERVOUS SYSTEM
Also known as: ciamatil, cianatil, cyamemazin, cyamepromazine, cyamepromezine
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Cyamemazine is a drug catalogued in DrugCentral. DrugCentral lists 13 molecular targets, including HTR2A, DRD3 and DRD1.
- Molecular targets: HTR2A, DRD3, DRD1 and DRD2 (13 listed in DrugCentral).
- ATC code: N05AA06 (Phenothiazines with aliphatic side-chain).
- Molecular formula: C19H21N3S; molecular weight 323.46 g/mol.
Mechanism & targets
Molecular targets (13)
| Target | Gene | Action | Activity |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2A | HTR2A | antagonist | Ki 8.80 |
| D(3) dopamine receptor | DRD3 | unknown | Ki 8.60 |
| D(1A) dopamine receptor | DRD1 | unknown | Ki 8.42 |
| D(2) dopamine receptor | DRD2 | unknown | Ki 8.24 |
| Muscarinic acetylcholine receptor M4 | CHRM4 | unknown | Ki 7.92 |
| 5-hydroxytryptamine receptor 2C | HTR2C | antagonist | Ki 7.90 |
| Muscarinic acetylcholine receptor M1 | CHRM1 | unknown | Ki 7.89 |
| Muscarinic acetylcholine receptor M3 | CHRM3 | unknown | Ki 7.50 |
| Muscarinic acetylcholine receptor M5 | CHRM5 | unknown | Ki 7.46 |
| Muscarinic acetylcholine receptor M2 | CHRM2 | unknown | Ki 7.38 |
| 5-hydroxytryptamine receptor 7 | HTR7 | antagonist | Ki 7.20 |
| 5-hydroxytryptamine receptor 1A | HTR1A | antagonist | Ki 6.30 |
| 5-hydroxytryptamine receptor 3A | HTR3A | unknown | Ki 5.53 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N05AA06 | NERVOUS SYSTEM › PSYCHOLEPTICS › ANTIPSYCHOTICS › Phenothiazines with aliphatic side-chain |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Coma | 3917.3 |
| Poisoning deliberate | 2441.1 |
| Drug abuse | 1298.8 |
| Somnolence | 896.4 |
| Miosis | 715.1 |
| Toxicity to various agents | 622.1 |
| Altered state of consciousness | 607.7 |
| Drug use disorder | 555.0 |
| Asphyxia | 442.4 |
| Intentional overdose | 412.3 |
| Substance use disorder | 410.3 |
| Rhabdomyolysis | 393.9 |
Chemical structure
| Molecular formula | C19H21N3S |
|---|---|
| Molecular weight | 323.46 g/mol |
| CAS number | 3546-03-0 |
| InChIKey | SLFGIOIONGJGRT-UHFFFAOYSA-N |
| PubChem CID | 62865 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Cyamemazine work?
Its molecular targets in DrugCentral include HTR2A (antagonist), DRD3, DRD1 and DRD2.
What is the chemical formula of Cyamemazine?
Cyamemazine has the molecular formula C19H21N3S and a molecular weight of 323.46 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 746 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2104153 — compound record and bioactivity
- PubChem CID 62865 — chemical identifiers
- DrugBank DB09000 — drug record
- FDA UNII A2JGV5CNU4 — substance identity
- UniProt P28223 (HTR2A) — target protein
- UniProt P35462 (DRD3) — target protein
- UniProt P21728 (DRD1) — target protein
- UniProt P14416 (DRD2) — target protein
- UniProt P08173 (CHRM4) — target protein
- UniProt P28335 (HTR2C) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.